1Cortelezzi A, Cattaneo C, Cristiani S, et al. Non - transferrin bound iron in myelodysplastic syndromes: a marker of ineffective erythro- poiesis. Hematol J,2000,1 (3) : 153.
2Milman N,Pedersen L M.The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer[J].Oncol Rep,2OO2,9(1):193-198.
3Munoz-fernandez M A,Arnas-portela R,Diaz-Nido J,et a1.Differential deffects of tumor nerosis factor on the growth and differentiation of neuroblastoma and glioma cells[J].Exp Cell Res,1991,194(1):161-164.
4Tanno T, Noel P,Miller JL. Growth differentiation factor 15 in ery-throid health and disease [ J]. Current Opinion in Hematology,2010,17(3):184 -190.
5Santini V,Girelli D,Sanna A,et al. Hepcidin levels and their deter-minants in different types of myelodysplastic syndromes [ J]. PlosOne,2011 ,6(8) :e23109.
6Chan LSA,Gu LC, Rauh MJ,et al. Iron overload accelerates devel-opment of leukaemia:evidence from mouse model[ J]. Blood,2010,116(21) :59 -60.
7Chan LSA,Buckstein R,Reis MD,et al. Iron overload and haemato-poiesis in MDS : does blood transfusion promote progression to AML.. Blood,2008,112:Abs 2685.
8Hartmann J, Sinzig U, Wulf G, et al. Evidence for a suppression ofthe colony forming capacity of erythroid progenitors by iron overloadin patients with MDS[ J]. Blood,2008 ,112: Abs 2694.
9Dayyani F, Conley AP, Strom SS, et al. Cause of death in patientswith lower-risk myelodysplastic syndrome [ J]. Cancer, 2010, 116(9):2174 -2179.
10Alessandrino EP, Della Porta MG, Bacigalupo A, et al. Prognosticimpact of pre-transplantation transfusion history and secondary ironoverload in patients with myelodysplastic syndrome undergoing allo-geneic stem cell transplantation: a GITMO study [ J]. Haematologi-ca,2010,95(3) :476 -484.
4Vanlet P, Homy H P, Bennet J M, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res, 2007, 31 (6) :727-736.
5Visconte V, Rogers H, Singh J, et al. SF3B1 haploinsuffciency leads to formation of ring sideroblasts in myelodysplastic syndromes. Blood, 2012,120(16) :3173-3186.
6Kikuchi S, Kobune M, lyama S, et al. Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome. Int J Hemato1,2012,95 ( 5 ) :527-534.
7Greenberg P L. Myelodysplastic syndromes: iron overload consequences and current chelating therapies. J Natl Compr Canc Netw, 2006,4( 1 ) :91-96.
